BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-08049820 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-08049820\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07216027-1457@assetmemo.bio
DTSTAMP:20261121T005813Z
DTSTART;VALUE=DATE:20280202
DTEND;VALUE=DATE:20280203
SUMMARY:PF-08049820: Phase 2 readout est. (NCT07216027)
DESCRIPTION:PF-08049820\, phase 2\, Atopic Dermatitis.\nStudy: A Study to L
 earn About Study Medicine Called PF-08049820 in People With Eczema\nEstima
 ted primary completion: 2 February 2028. This is a ClinicalTrials.gov esti
 mate\, not a confirmed readout date\, and it can move.\nDrug page: https:/
 /assetmemo.bio/drug/pf-08049820#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07216027
URL:https://assetmemo.bio/drug/pf-08049820#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
